DexCom Common stock, shares authorized (in shares) remained flat by 0.0% to $800.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $800.00M to $800.00M. Over 4 years (FY 2020 to FY 2025), Common stock, shares authorized (in shares) shows an upward trend with a 41.4% CAGR.
An increase in authorized shares often signals potential future capital raising or stock split activity.
This is the maximum number of shares that a company is legally permitted to issue according to its corporate charter. It...
Standard corporate governance metric; usually set significantly higher than issued shares to provide flexibility.
other_common_stock_shares_authorized| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00M | $200.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M | $800.00M |
| QoQ Change | — | +0.0% | +300.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | +0.0% | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |